Brown Doctor Researched Alzheimer's Drug Before FDA Approval

(Providence, RI)--There is a Rhode Island tie to the FDA approval of a new drug targeting Alzheimer's disease.The injectable drug called Aducanumab [[ adu-can-you-mab ]] is from Biogen and was researched by Brown University's Dr. Stephen Salloway.It is intended to slow cognitive decline in early-stage dementia patients.

Photo: Getty Images